Source Post
Andrew Summers of Summers Value Partners on healthcare, biotech $GILD, $QURE and $ELMD | S08 E02
Jan 21, 2026
The creator discusses their strategy of focusing on undervalued, underfollowed healthcare companies, often special situations, and holding them long-term. They highlight the complexity of the healthcare sector due to regulatory changes (FDA, government policies) and commercial dynamics (payers, CMS), which can make it uncomfortable for generalist investors.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.